Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 21, 2023
Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation
Karin Jordan, Alexandre Chan, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy
Fausto Roila, David Warr, Paul J Hesketh, et al.
Cancer
|
May 14, 2016
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy
Paul J Hesketh, Ian D Schnadig, Lee S Schwartzberg, et al.
Onkologie
|
March 15, 2013
Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment
Maike de Wit, Petra Ortner, Hans-Peter Lipp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 27, 2025
Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
Karin Jordan, Evandro de Azambuja, María Ángeles García Del Barrio, et al.
BMC Cancer
|
April 27, 2020
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution
Sandra Sauer, Petra Pavel, Anita Schmitt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 18, 2015
PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study
Heike Schmidt, Daniela Merkel, Michael Koehler, et al.
BMC Cancer
|
September 29, 2020
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from a randomized clinical trial of response in subjects by cancer type
Cindy Weinstein, Karin Jordan, Stuart Green, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 15, 2013
Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study
Karin Jordan, Irina Proskorovsky, Philip Lewis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 2, 2009
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study
Bernardo L Rapoport, Karin Jordan, Judith A Boice, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 21, 2023
Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation
Karin Jordan, Alexandre Chan, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy
Fausto Roila, David Warr, Paul J Hesketh, et al.
Cancer
|
May 14, 2016
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy
Paul J Hesketh, Ian D Schnadig, Lee S Schwartzberg, et al.
Onkologie
|
March 15, 2013
Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment
Maike de Wit, Petra Ortner, Hans-Peter Lipp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 27, 2025
Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
Karin Jordan, Evandro de Azambuja, María Ángeles García Del Barrio, et al.
BMC Cancer
|
April 27, 2020
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution
Sandra Sauer, Petra Pavel, Anita Schmitt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 18, 2015
PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study
Heike Schmidt, Daniela Merkel, Michael Koehler, et al.
BMC Cancer
|
September 29, 2020
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from a randomized clinical trial of response in subjects by cancer type
Cindy Weinstein, Karin Jordan, Stuart Green, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 15, 2013
Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study
Karin Jordan, Irina Proskorovsky, Philip Lewis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 2, 2009
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study
Bernardo L Rapoport, Karin Jordan, Judith A Boice, et al.
Page
of 11